CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C04804 | BRD-K07569193 | SA-1459454 | -- | -- | -- | Details |
| C04805 | BRD-K07572174 | curcumin | PTGS1; PTGS2 | Cyclooxygenase inhibitor; Lipoxygenase inhibitor; NFKB pathway inhibitor; Histone acetyltransferase inhibitor | -- | Details |
| C04806 | BRD-K07572455 | BRD-K07572455 | -- | -- | -- | Details |
| C04807 | BRD-K07576726 | BRD-K07576726 | -- | -- | -- | Details |
| C04808 | BRD-K07577534 | BRD-K07577534 | -- | -- | -- | Details |
| C04809 | BRD-K07581216 | BRD-K07581216 | -- | -- | -- | Details |
| C04810 | BRD-K07588901 | BRD-K07588901 | -- | -- | -- | Details |
| C04811 | BRD-K07589203 | BRD-K07589203 | -- | -- | -- | Details |
| C04812 | BRD-K07591425 | BRD-K07591425 | -- | -- | -- | Details |
| C04813 | BRD-K07591847 | BRD-K07591847 | -- | -- | -- | Details |
| C04814 | BRD-K07594626 | BRD-K07594626 | -- | -- | -- | Details |
| C04815 | BRD-K07600484 | BRD-K07600484 | -- | -- | -- | Details |
| C04816 | BRD-K07601300 | BRD-K07601300 | -- | -- | -- | Details |
| C04817 | BRD-K07602825 | BRD-K07602825 | -- | -- | -- | Details |
| C04818 | BRD-K07604665 | SA-1921574 | -- | -- | -- | Details |
| C04819 | BRD-K07609594 | BRD-K07609594 | -- | -- | -- | Details |
| C04820 | BRD-K07609981 | dexloxiglumide | CCKAR | CCK receptor antagonist | -- | Details |
| C04821 | BRD-K07612980 | sparfloxacin | -- | -- | -- | Details |
| C04822 | BRD-K07613753 | BRD-K07613753 | -- | -- | -- | Details |
| C04823 | BRD-K07614312 | BRD-K07614312 | -- | -- | -- | Details |
| C04824 | BRD-K07615667 | BRD-K07615667 | -- | -- | -- | Details |
| C04825 | BRD-K07616985 | BRD-K07616985 | -- | -- | -- | Details |
| C04826 | BRD-K07624584 | BRD-K07624584 | -- | -- | -- | Details |
| C04827 | BRD-K07625901 | BRD-K07625901 | -- | -- | -- | Details |
| C04828 | BRD-K07627743 | BRD-K07627743 | -- | -- | -- | Details |
| C04829 | BRD-K07634536 | BRD-K07634536 | -- | -- | -- | Details |
| C04830 | BRD-K07642375 | BRD-K07642375 | -- | -- | -- | Details |
| C04831 | BRD-K07653295 | BRD-K07653295 | -- | -- | -- | Details |
| C04832 | BRD-K07658499 | BRD-K07658499 | -- | -- | -- | Details |
| C04833 | BRD-K07660364 | BRD-K07660364 | -- | -- | -- | Details |
| C04834 | BRD-K07662722 | BRD-K07662722 | -- | -- | -- | Details |
| C04835 | BRD-K07665396 | BRD-K07665396 | -- | -- | -- | Details |
| C04836 | BRD-K07666543 | BRD-K07666543 | -- | -- | -- | Details |
| C04837 | BRD-K07667606 | BRD-K07667606 | -- | -- | -- | Details |
| C04838 | BRD-K07667635 | BRD-K07667635 | -- | -- | -- | Details |
| C04839 | BRD-K07667918 | linsitinib | IGF1R; INSR | IGF-1 inhibitor | -- | Details |
| C04840 | BRD-K07668032 | BRD-K07668032 | -- | -- | -- | Details |
| C04841 | BRD-K07678162 | BRD-K07678162 | -- | -- | -- | Details |
| C04842 | BRD-K07686903 | BRD-K07686903 | -- | -- | -- | Details |
| C04843 | BRD-K07688551 | BRD-K07688551 | -- | -- | -- | Details |
| C04844 | BRD-K07689069 | BRD-K07689069 | -- | -- | -- | Details |
| C04845 | BRD-K07689498 | BRD-K07689498 | -- | -- | -- | Details |
| C04846 | BRD-K07691486 | roscovitine | CDK2; CDK7; CDK9 | CDK inhibitor | -- | Details |
| C04847 | BRD-K07695007 | BRD-K07695007 | -- | -- | -- | Details |
| C04848 | BRD-K07697589 | BRD-K07697589 | -- | -- | -- | Details |
| C04849 | BRD-K07699301 | BRD-K07699301 | -- | -- | -- | Details |
| C04850 | BRD-K07700224 | BRD-K07700224 | -- | -- | -- | Details |
| C04851 | BRD-K07702264 | BRD-K07702264 | -- | -- | -- | Details |
| C04852 | BRD-K07706477 | BRD-K07706477 | -- | -- | -- | Details |
| C04853 | BRD-K07708492 | BRD-K07708492 | -- | -- | -- | Details |
| C04854 | BRD-K07712233 | BRD-K07712233 | -- | -- | -- | Details |
| C04855 | BRD-K07727895 | BRD-K07727895 | -- | -- | -- | Details |
| C04856 | BRD-K07734771 | BRD-K07734771 | -- | -- | -- | Details |
| C04857 | BRD-K07734969 | BRD-K07734969 | -- | -- | -- | Details |
| C04858 | BRD-K07736136 | VX-702 | MAPK14 | P38 MAPK inhibitor | -- | Details |
| C04859 | BRD-K07740919 | BRD-K07740919 | -- | -- | -- | Details |
| C04860 | BRD-K07748118 | BRD-K07748118 | -- | -- | -- | Details |
| C04861 | BRD-K07753030 | acecainide | -- | -- | -- | Details |
| C04862 | BRD-K07755570 | BRD-K07755570 | -- | -- | -- | Details |
| C04863 | BRD-K07756997 | BRD-K07756997 | -- | -- | -- | Details |
| C04864 | BRD-K07760433 | BRD-K07760433 | -- | -- | -- | Details |
| C04865 | BRD-K07762528 | BRD-K07762528 | -- | -- | -- | Details |
| C04866 | BRD-K07762753 | aminopurvalanol-a | CDK2; CDK5; CDK1 | CDK inhibitor; Tyrosine kinase inhibitor | -- | Details |
| C04867 | BRD-K07768565 | BRD-K07768565 | -- | -- | -- | Details |
| C04868 | BRD-K07770425 | BRD-K07770425 | -- | -- | -- | Details |
| C04869 | BRD-K07778122 | BRD-K07778122 | -- | -- | -- | Details |
| C04870 | BRD-K07781799 | BRD-K07781799 | -- | -- | -- | Details |
| C04871 | BRD-K07781811 | BRD-K07781811 | -- | -- | -- | Details |
| C04872 | BRD-K07786204 | BRD-K07786204 | -- | -- | -- | Details |
| C04873 | BRD-K07790303 | BRD-K07790303 | -- | -- | -- | Details |
| C04874 | BRD-K07790550 | mavoglurant | -- | -- | -- | Details |
| C04875 | BRD-K07790824 | BRD-K07790824 | -- | -- | -- | Details |
| C04876 | BRD-K07794261 | BRD-K07794261 | -- | -- | -- | Details |
| C04877 | BRD-K07796595 | BRD-K07796595 | -- | -- | -- | Details |
| C04878 | BRD-K07798964 | BRD-K07798964 | -- | -- | -- | Details |
| C04879 | BRD-K07798980 | PSI-6130 | -- | -- | -- | Details |
| C04880 | BRD-K07799833 | BRD-K07799833 | -- | -- | -- | Details |
| C04881 | BRD-K07802542 | BRD-K07802542 | -- | -- | -- | Details |
| C04882 | BRD-K07807999 | BRD-K07807999 | -- | -- | -- | Details |
| C04883 | BRD-K07809895 | BRD-K07809895 | -- | -- | -- | Details |
| C04884 | BRD-K07812227 | BRD-K07812227 | -- | -- | -- | Details |
| C04885 | BRD-K07813434 | BRD-K07813434 | -- | -- | -- | Details |
| C04886 | BRD-K07817703 | BRD-K07817703 | -- | -- | -- | Details |
| C04887 | BRD-K07820537 | BRD-K07820537 | -- | -- | -- | Details |
| C04888 | BRD-K07825644 | BRD-K07825644 | -- | -- | -- | Details |
| C04889 | BRD-K07826724 | BRD-K07826724 | -- | -- | -- | Details |
| C04890 | BRD-K07833219 | BRD-K07833219 | -- | -- | -- | Details |
| C04891 | BRD-K07836769 | BRD-K07836769 | -- | -- | -- | Details |
| C04892 | BRD-K07839394 | BRD-K07839394 | -- | -- | -- | Details |
| C04893 | BRD-K07850148 | BRD-K07850148 | -- | -- | -- | Details |
| C04894 | BRD-K07852185 | BRD-K07852185 | -- | -- | -- | Details |
| C04895 | BRD-K07852637 | BRD-K07852637 | -- | -- | -- | Details |
| C04896 | BRD-K07855097 | BRD-K07855097 | -- | -- | -- | Details |
| C04897 | BRD-K07857022 | alvimopan | OPRD1; OPRK1; OPRM1 | Opioid receptor antagonist | -- | Details |
| C04898 | BRD-K07859598 | GW-5074 | RAF1 | RAF inhibitor; Leucine rich repeat kinase inhibitor | -- | Details |
| C04899 | BRD-K07861364 | BRD-K07861364 | -- | -- | -- | Details |
| C04900 | BRD-K07870648 | BRD-K07870648 | -- | -- | -- | Details |
| C04901 | BRD-K07872006 | BRD-K07872006 | -- | -- | -- | Details |
| C04902 | BRD-K07877311 | BRD-K07877311 | -- | -- | -- | Details |
| C04903 | BRD-K07877451 | BRD-K07877451 | -- | -- | -- | Details |